Insmed Incorporated
INSM
$72.65
$2.453.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -21.91% | -19.44% | -15.36% | -36.62% | -55.66% |
| Total Depreciation and Amortization | 5.14% | 3.34% | 14.98% | 19.45% | 13.45% |
| Total Amortization of Deferred Charges | -3.58% | -1.73% | 10.67% | 26.20% | 37.64% |
| Total Other Non-Cash Items | -8.39% | 16.93% | 23.50% | 168.54% | 298.24% |
| Change in Net Operating Assets | 91.90% | -30.80% | -250.05% | -1,917.91% | -696.47% |
| Cash from Operations | -27.53% | -21.66% | -24.25% | -29.98% | -33.91% |
| Capital Expenditure | -64.98% | -9.34% | -21.51% | -25.87% | -34.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -166.86% | -267.63% | 310.32% | -62.76% | -751.27% |
| Cash from Investing | -160.81% | -247.70% | 282.70% | -72.23% | -546.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -114.46% | 64.81% | 14.74% | -170.11% | -102.50% |
| Issuance of Common Stock | 600.73% | 321.59% | 163.96% | -43.20% | -45.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -206.81% | 100.00% | 100.00% | 97.85% | 93.15% |
| Cash from Financing | 696.15% | 65.49% | 10.26% | -78.15% | -78.77% |
| Foreign Exchange rate Adjustments | -422.80% | 150.33% | 156.51% | -1,996.43% | 74.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.28% | -135.41% | 222.11% | -182.34% | -265.61% |